0 Comentários
0 Compartilhamentos
216 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Veterinary Biologics Market Growth: Opportunities in Monoclonal Antibodies and Emerging MarketsThe management of animal diseases is evolving rapidly, driven by technological breakthroughs in biotechnology and a growing global emphasis on preventive animal healthcare. This is creating significant opportunities for the Veterinary Biologics Market Growth. The market is projected to expand from USD 2.72 billion in 2025 to USD 3.51 billion by 2030, driven by the emergence of monoclonal...0 Comentários 0 Compartilhamentos 316 Visualizações 0 Anterior
-
Biologics and Injectable Drug Production Drive Growth in the Sterility Testing MarketAccording to a new report by Polaris Market Research, the global sterility testing market was valued at USD 1,104.65 million in 2023 and is projected to reach USD 2,387.31 million by 2032, expanding at a CAGR of 9% over the forecast period. Growth is underpinned by rising biopharmaceutical output, expanding regulatory requirements, and accelerating automation across pharmaceutical and...0 Comentários 0 Compartilhamentos 187 Visualizações 0 Anterior
-
Biologics Are Transforming the WAIHA MarketBiologics are revolutionising the treatment of warm autoimmune hemolytic anemia (WAIHA), offering new options for patients who do not respond adequately to traditional therapies such as corticosteroids and immunosuppressants. Rituximab, a monoclonal antibody targeting CD20, has become a standard second-line therapy for WAIHA, demonstrating significant efficacy in reducing hemolysis and...0 Comentários 0 Compartilhamentos 18 Visualizações 0 Anterior
-
Biologics Contract Manufacturing Market Trends Driving the Future of Biopharmaceutical ProductionThe Biologics Contract Manufacturing Market is poised for exceptional growth from 2025 to 2033, fueled by the booming biopharmaceutical industry, the rising complexity of biologic drugs, and the strategic shift of pharmaceutical companies toward outsourcing to reduce costs and accelerate commercialization. The market is projected to be valued at approximately USD 23.6...0 Comentários 0 Compartilhamentos 554 Visualizações 0 Anterior
-
Biologics Manufacturing Market: Innovative Bioprocessing Technologies Creating New OpportunitiesMarket Overview Polaris Market Research’s latest research report, titled Biologics Manufacturing Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a...0 Comentários 0 Compartilhamentos 743 Visualizações 0 Anterior
-
Biologics Revolutionizing Uveitis Treatment: A New Era in Eye CareUveitis, an inflammatory condition affecting the uveal tract of the eye, remains a leading cause of preventable blindness worldwide. For decades, corticosteroids have been the cornerstone of treatment, but their long-term use is associated with significant side effects, including cataracts and glaucoma. The emergence of biologic therapies is transforming the treatment landscape, offering...0 Comentários 0 Compartilhamentos 56 Visualizações 0 Anterior
-
Biologics Safety Testing Market - Pharmaceutical Integration and Quality Assurance CoordinationMarket Overview Pharmaceutical integration and quality assurance coordination represent essential capabilities advancing biologics testing through testing specialist networks, multidisciplinary coordination, and comprehensive programs enabling systematic testing access and optimized safety outcomes. The Biologics Safety Testing Market transformation toward integration substantially improve...0 Comentários 0 Compartilhamentos 246 Visualizações 0 Anterior
-
Biologics Safety Testing Market - Regulatory Evidence and Compliance DocumentationMarket Overview Regulatory evidence and compliance documentation represent essential capabilities establishing biologics safety testing value through rigorous compliance studies and regulatory outcome documentation supporting evidence-based testing adoption and optimal regulatory compliance outcomes. The Biologics Safety Testing Market transformation toward evidence emphasis substantially...0 Comentários 0 Compartilhamentos 230 Visualizações 0 Anterior
-
Biopharmaceutical Market to Reach USD 918.75 Billion by 2033 Fueled by Innovation in Biologics and Advanced TherapiesThe global biopharmaceutical market size was valued at USD 450.89 billion in 2024 and is estimated to grow from USD 487.99 billion in 2025 to reach USD 918.75 billion by 2033, growing at a CAGR of 8.23% during the forecast period (2025–2033). How Is the Biopharmaceutical Market Analyzed and What Research Methodology Is Used? The study examines...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Biosimilar and Biologics Market Industry Report 2036: Key Trends, Regional Insights, and Strategic DevelopmentsThe Biosimilar and Biologics Market is expected to witness robust expansion as healthcare systems worldwide increasingly adopt cost-effective biologic therapies to improve patient access and reduce treatment costs. According to Future Market Insights (FMI), the market is projected to grow from USD 604.4 million in 2026 to USD 1,257.3 million by 2036, registering a 7.6% CAGR during the forecast...0 Comentários 0 Compartilhamentos 377 Visualizações 0 Anterior
-
Biosimilar and Biologics Market Industry Report 2036: Key Trends, Regional Insights, and Strategic DevelopmentsThe Biosimilar and Biologics Market is expected to witness robust expansion as healthcare systems worldwide increasingly adopt cost-effective biologic therapies to improve patient access and reduce treatment costs. According to Future Market Insights (FMI), the market is projected to grow from USD 604.4 million in 2026 to USD 1,257.3 million by 2036, registering a 7.6% CAGR during the forecast...0 Comentários 0 Compartilhamentos 386 Visualizações 0 Anterior
-
Clinical Trial Supplies Market Opportunities in Decentralized ResearchThe global Clinical Trial Supplies Market was valued at USD 5.7 billion in 2025 and is projected to reach USD 10.7 billion by 2033, expanding at a CAGR of 8.4% from 2026 to 2033. The market is being reshaped by rising pharmaceutical R&D investments, increasing clinical trial complexity, the globalization of research, and the growing development of biologics and personalized...0 Comentários 0 Compartilhamentos 700 Visualizações 0 Anterior
-
Healthcare Contract Development and Manufacturing Organization Market Forecast Shows Strong Industry ExpansionA new medicine does not reach the market through research alone. Between discovering a promising compound and producing a commercially available therapy lies a long chain of development, testing, formulation, manufacturing, quality control, regulatory work, and supply management. As pharmaceutical and biotechnology companies build increasingly complex pipelines, many are choosing not to develop...0 Comentários 0 Compartilhamentos 577 Visualizações 0 Anterior
-
Cancer Biologics Market to Reach USD 219.58 Billion by 2033, Growing at a CAGR of 6.7%The global Cancer Biologics Market is witnessing significant growth, driven by the increasing prevalence of cancer, advancements in biotechnology, and the rising adoption of targeted therapies. Cancer biologics, including monoclonal antibodies, vaccines, and cell-based therapies, are transforming oncology treatment by offering improved efficacy and reduced side effects compared to...0 Comentários 0 Compartilhamentos 626 Visualizações 0 Anterior
-
Gastrointestinal Therapeutics Market Demand, Opportunities and Competitive LandscapeThe global gastrointestinal drugs market is witnessing strong growth due to the increasing prevalence of digestive disorders, rising healthcare awareness, expanding biologics development, and growing pharmaceutical innovations. Gastrointestinal drugs are widely used to treat disorders affecting the digestive tract, including irritable bowel syndrome (IBS), ulcerative colitis, Crohn’s...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Biological Safety Testing Products and Services Market to Reach USD 11.93 Billion by 2033, Driven by Rising Biologics and Vaccine DevelopmentThe global biological safety testing products and services market size was valued at USD 4.82 billion in 2024 and is projected to grow from USD 5.33 billion in 2025 to reach USD 11.93 billion by 2033, growing at a CAGR of 10.59% during the forecast period (2025-2033). How Is the Biological Safety Testing Products and Services Market Analyzed and What Research...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Global Biologics Contract Development Market Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2025-2034The market research for the global Biologics Contract Development market is an accumulation of first-hand facts and quantitative and qualitative evaluation and analysis for the forecast period (2024-2032). The report offers a comprehensive assessment of macro-economic indicators, parent market trends, and several factors influencing the market dynamics. In addition, it also...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek